Top Texas Biotech Startups (88)
Aggredyne is a biomedical company developing diagnostic devices for platelet therapy.
CUSABIO is a National High-Tech Enterprise with research, production and sales in one.
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory...
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
Vascular Perfusion Solutions develops medical devices designed to preserve and resuscitate vascularized organs.
Creating fully human monoclonal antibodies that target and neutralize HIV and other infectious diseases.
Nano3D Biosciences develops products for in vitro cell culturing applications.
Tackling a global health threat like antimicrobial resistance is not for the faint of heart, but the experienced and innovative team at Pattern Bioscience is on a mission to do it. Each year, drug-resistant bacterial infections claim more than a million lives globally and cost our healthcare system billions of dollars. Traditional diagnostic methods for bacterial infections remain rooted in...
Conceptual MindWorks, Inc. (CMI) is a diversified basic and applied research, consulting, and software engineering company with over 23 years of providing health-related software, bioinformatics, biotechnology, scientific, and technical solutions to the public and private sectors.
Glycos Biotechnologies is an International biochemical company commercializing sustainable chemicals made from renewable feedstocks.
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies that target neoantigens arising from genomic mutations. We have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific killer T cells to large cancer...
ImmuneSensor Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system. Based on groundbreaking discoveries from the research of the 2019 Breakthrough Prize awardee, Dr. Zhijian “James” Chen, we are pioneering a differentiated approach to both STING activators to boost anticancer immunity and cGAS inhibitors to suppress autoimmunity...
Neurolink is an early-stage company developing a novel therapy for the treatment of epilepsy.
G-CON Manufacturing, Inc.’s prefabricated, turnkey cleanroom systems represent a significant transition to forward thinking in pharmaceutical and biopharmaceutical processing. G-CON Manufacturing, the innovator of autonomous cleanroom PODs, turned the challenges experienced by the biopharmaceutical industry into readily deployable, flexible, mobile and scalable cleanroom solutions. PODs are ideal for multi-product sites, rigorous containment needs, and on demand scaling of production and...
We're an advanced genomic services company offering assays compliant with FDA and EPA enforced regulations to assist our customers in their regulatory submissions. Combined, our company's founders possess more than a century of experience in the industry. Throw in a team of leading scientists who have designed and executed countless studies satisfying US, European, and Japanese regulatory agencies, and you've got...
Allied BioScience is dedicated to developing innovative solutions with sound science, to create cleaner human environments.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Phantom is creating a human-machine interfacing system for lifelike control of technology.
Opexa Therapeutics develops patient-specific immunotherapies for the treatment of multiple sclerosis.
